Cargando…
Botulinum toxin type A in the treatment of Raynaud’s phenomenon: A three-year follow-up study
OBJECTIVE: Raynaud’s phenomenon consists of vasospastic disease of the digital arteries after exposure to cold or stress. It causes an important reduction in the patient’s quality of life when severe. The available treatments do not always offer favorable results. METHODS: A 3-year retrospective stu...
Autores principales: | Medina, Susana, Gómez-Zubiaur, Alba, Valdeolivas-Casillas, Nuria, Polo-Rodríguez, Isabel, Ruíz, Lucia, Izquierdo, Carmen, Guirado, Cristina, Cabrera, Alicia, Trasobares, Lidia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Research and Education Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267752/ https://www.ncbi.nlm.nih.gov/pubmed/30501848 http://dx.doi.org/10.5152/eurjrheum.2018.18013 |
Ejemplares similares
-
Botulinum toxin A in the treatment of Raynaud's phenomenon: a systematic review
por: Żebryk, Paweł, et al.
Publicado: (2015) -
Use of Botulinum Toxin A to Treat Chemotherapy-Induced Raynaud’s Phenomenon
por: Potluri, Thrisha K, et al.
Publicado: (2021) -
Improvement of pterygium inversum unguis and Raynaud phenomenon with interdigital botulinum toxin injections
por: Kim, Daniel J., et al.
Publicado: (2022) -
Botulinum toxin in the treatment of Raynaud phenomenon in patients with systemic sclerosis: a systemic review
por: Cai, Ruyi, et al.
Publicado: (2022) -
Raynaud's Phenomenon
por: Shah, Jehan, et al.
Publicado: (2013)